AFP and Hepatic fibrosis: Regardless of the availability of data from early on- and off-treatment surveillance sessions, concurrently high LS and AFP values indicating leftover liver fibrosis and regeneration burden at Y3PSVR alert both physicians and patients that continuing or starting careful long-term surveillance is necessary.